alexa Peptide-tagged Nanocarriers For Targeted Delivery Of Cytokines To The Tumor Vasculature | 70109
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology

A Corti, F Curnis, AM Gasparri, M Ghitti, A Sacchi, F Sudati, M Fiocchi, A Gori, S Valtorta, MR Moresco, F Pastorino, M Ponzoni and G Musco
San Raffaele Scientific Institute, Italy
CNR, Milan
Istituto G Gaslini, Italy
Vita-Salute San Raffaele University, Italy
Posters & Accepted Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439-C1-050
Abstract
Statement of the Problem: Peptides containing the NGR motif have proven useful for delivering cytokines and other compounds to tumors. For example, we have previously shown that NGR peptides can be used for delivering TNF-alpha (TNF) to CD13-positive tumor vessels, either in the form of peptide-protein fusion product (called NGR-TNF, currently tested in Phase II and III clinical studies with evidence of activity), or in the form of TNF-bearing gold nanoparticles. The good results obtained with these drugs in preclinical and clinical studies highlight the usefulness and versatility of NGR peptides for the development of tumor-homing cytokines. A major problem associated with the use of NGR is that its asparagine residue has a strong propensity to undergo rapid deamidation. This reaction, converts NGR into isoDGR, causing receptor switching from CD13 to integrins, with potentially important pharmacological and toxicological implications. Thus, the development of stable CD13 ligands and nanoparticles is desirable. Methodology: To prevent asparagine deamidation, we have chemically modified NGR peptides and investigated their CD13 binding properties. Furthermore, using conventional and chemically modified NGR peptides we have developed peptide-tagged nanodrugs, including TNF-bearing nanogold, and investigated their therapeutic properties in animal models. Findings: Biochemical and structural studies showed that chemical modification of NGR completely prevents asparagine deamidation without impairing CD13 recognition. Studies in animal models showed that the modified peptide can be exploited for delivering radio- and fluorescent-labeled compounds, liposomal doxorubicin and TNF-bearing nanogold to tumors, with an efficiency similar to that of a conventional NGR. Conclusion & Significance: These findings suggest that NGR can be chemically modified to obtain a stable and efficient CD13 ligand, which can be used for the development of tumor-homing gold nanoparticles. The novel peptide-tagged gold nanoparticles could be exploited as a stable platform for delivering TNF and other cytokines to tumor vasculature.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7